Study for kids with bleeding disorder canceled before it began
NCT ID NCT02472665
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study aimed to measure how a medicine called FANHDI® works in children under 6 with severe von Willebrand disease, a bleeding disorder. The plan was to give the medicine and track its effects over time. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Sant Joan de Déu Barcelona
Esplugues de Llobregat, Barcelona, 08950, Spain
-
Hospital Universitario La Paz
Madrid, Spain
-
Hospital Universitario Miguel Servet
Zaragoza, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Sevilla, 41013, Spain
Conditions
Explore the condition pages connected to this study.